<DOC>
	<DOCNO>NCT02704364</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , activity NGM282 patient Primary Sclerosing Cholangitis .</brief_summary>
	<brief_title>Phase 2 Study NGM282 Patients With Primary Sclerosing Cholangitis</brief_title>
	<detailed_description />
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>Confirmed diagnosis PSC Clinically significant acute chronic liver disease etiology PSC Secondary IgG4 relate sclerosing cholangitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>